Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2023-05-21 Share Issue/Capital Cha…
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - BXN 6 pages 30.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the number and type of securities to be quoted, issue dates, and related shareholder approvals. It is a regulatory announcement about the listing of new securities rather than a financial report or earnings release. The content aligns with announcements about share issues or capital changes. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief notice or a report publication announcement.
2023-05-21 English
Cleansing Notice 1 page 547.3KB
Capital/Financing Update Classification · 95% confidence The document is a Cleansing Notice issued by Bioxyne Limited pursuant to Section 708A(5)(e) of the Corporations Act. It relates to the issue of 6,000,000 shares and compliance with disclosure requirements under the Corporations Act. The document is short (1358 characters) and serves as an announcement regarding a share issue and compliance, not a full financial report or detailed capital update. It specifically references an Appendix 2A (a form related to share issues) but does not contain detailed financial data or analysis. Therefore, it is best classified as a Capital/Financing Update (CAP) since it concerns share issuance and related compliance notices.
2023-05-21 English
Results of Meeting 3 pages 153.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF GENERAL MEETING' and details the voting outcomes of resolutions passed at a General Meeting held on 5 May 2023. It includes a voting summary report with votes for, against, abstentions, and exclusions for various resolutions such as approval of share issues, election of directors, and approval of incentive plans. The document references compliance with Listing Rule 3.13.2 and Corporations Act Section 251AA(2), which relate to disclosure of voting results. There is no financial data, management discussion, or report content; rather, it is an official announcement of the voting results from a shareholder meeting. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4991 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2023-05-04 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 265.0KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'REPORT FOR THE QUARTER ENDED 31 MARCH 2023' and contains detailed financial and operational information for Bioxyne Limited for the quarter ending March 31, 2023. It includes unaudited sales revenue, cash flow statements, operating cash inflows and outflows, loan details, and other financial metrics. The presence of an Appendix 4C Quarterly cash flow report, which is a regulatory requirement for entities listed on the ASX, further confirms this is a quarterly financial report. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content is consistent with an Interim / Quarterly Report, providing substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, the appropriate classification is 'Interim / Quarterly Report' (IR). Q3 2023
2023-04-23 English
Notice of Meeting Proxy Form Independent Experts Report 142 pages 2.8MB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'NOTICE OF GENERAL MEETING Explanatory Memorandum and Proxy Form' and includes detailed information about resolutions to be voted on at a General Meeting scheduled for 5 May 2023. It contains multiple resolutions related to share issues, director elections, approval of an equity incentive plan, and acquisition approvals. The document also includes proxy voting instructions and voting exclusion statements. The presence of a Notice of Meeting, Explanatory Memorandum, and Proxy Form indicates this is material sent to shareholders to provide information and request votes for the meeting. It is not a report of voting results, nor is it a financial report or earnings release. Therefore, the document fits the definition of a Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the solicitation material itself, not just an announcement of a meeting or report publication.
2023-04-05 English
Letter to Shareholders re Notice of Meeting 1 page
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a notice and proxy form for a General Meeting of shareholders, dated 5 April 2023, with instructions on how to vote and lodge proxies. It does not contain financial data, results, or detailed reports but is a communication to shareholders about the meeting and voting process. The document length is short (1884 characters) and it explicitly refers to the Notice of Meeting and proxy form, which are materials typically sent to shareholders to provide information and request votes for meetings. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI).
2023-04-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.